Home Johnson & Johnson Medical Aesthetics Global Leadership Visits Mylike: Strategic Partnership Enters a New Chapter

Johnson & Johnson Medical Aesthetics Global Leadership Visits Mylike: Strategic Partnership Enters a New Chapter

Apr 17, 2026 12:38 CST Updated 12:38
Johnson & Johnson

Medical Device R&D and Manufacturer

Recently, Alenka Brzuljat, Global President of the Aesthetics and Reconstructive Division of Johnson & Johnson Medical Technologies, led the core management team of Johnson & Johnson Medical Technologies China to visit Shanghai Mylike Medical Aesthetic Institution. A strategic meeting and cooperation discussion were held with the Mylike management and medical team. It is reported that Mylike is the only direct-to-consumer medical aesthetic brand chosen by the global senior management team of Johnson & Johnson Medical Aesthetics for their visit to China.

Johnson & Johnson and [Company Name] Join Forces to Deepen Cooperation in Core Fields

Accompanied by the management of Meilai, President Alenka Brzuljat and her team first visited the flagship medical aesthetics store of Meilai located in the center of Shanghai. This institution is a global core strategic partner of Johnson & Johnson's Allura and Mentor, a diamond-level cooperative institution of Allura for ten years, and an officially designated surgical teaching base.

After comprehensively evaluating the medical capabilities, technical standards, service criteria, and customer reputation of the institution, President Alenka Brzuljat stated that Shanghai Meilai meets the high standards of global medical aesthetic institutions in terms of medical quality, technological innovation, academic leadership, and customer experience. It is a trustworthy and strategically valuable partner for Johnson & Johnson in China.

During the talks, the two parties engaged in in-depth discussions and reached multiple consensuses on core issues such as the clinical promotion of Allurion's new products, the co-construction of a global physician training base, the joint formulation of industry standards, and the development of customized breast aesthetics solutions based on Eastern aesthetics. Both parties clearly stated that they will continue to deepen cooperation in the future, achieving resource complementarity and synergistic efforts in areas such as technology empowerment, academic co-construction, new product launches, and physician training, setting a benchmark for global medical aesthetics collaboration.

Join Hands for Win-Win Cooperation and Open a New Chapter

It is reported that Johnson & Johnson and Meilai have maintained a close strategic cooperative relationship over the years. In 2018, Shanghai Meilai officially received the title of "Platinum Hospital" from Johnson & Johnson Mentor, marking a new phase in their cooperation. In 2019, the global management team of Johnson & Johnson visited Shanghai Meilai for strategic cooperation exchanges. In recent years, the cooperation between the two parties has continued to deepen. In 2024, they jointly held the South China Endoscopic Breast Augmentation Technology Summit Forum; in 2025, Beijing Meilai became the only "Fuyao Plan" cooperative institution in North China region by Johnson & Johnson Mentor and the first Auroa Breast Surgery Training Center in North China. In the same year, Yunnan Huamei Meilai received the exclusive authorization of Johnson & Johnson MENTOR Star Platinum implants in China. This series of cooperations covered multiple regional Meilai institutions in Shanghai, Shenzhen, Beijing, and Yunnan, ranging from brand authorization to technical training, from product launch to clinical application, fully demonstrating Johnson & Johnson's high recognition of Meilai's professional strength, as well as showcasing the deep strategic partnership between the two parties in the field of breast plastic surgery.

The visit of Johnson & Johnson's global senior executives to Mylike is not only a recognition by Johnson & Johnson of Mylike’s medical capabilities, compliance operations, and industry influence, but also marks the beginning of a new chapter in their strategic cooperation. In the future, through close collaboration between Mylike and Johnson & Johnson, supported by global technology and premium implant products, Chinese beauty seekers will experience safer, more precise, and natural advanced medical aesthetic services.